SW
MACK

SVB Wealth’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

SVB Wealth’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,883
Closed -$125K – 513
2016
Q4 		$125K Sell
3,883
-2,288
-37% -$97.6K 0.01% 474
2016
Q3 		$308K Hold
6,171
– – 0.01% 433
2016
Q2 		$262K Hold
6,171
– – 0.01% 444
2016
Q1 		$406K Hold
6,171
– – 0.02% 388
2015
Q4 		$384K Sell
6,171
-2,518
-29% -$177K 0.02% 420
2015
Q3 		$582K Hold
8,689
– – 0.02% 385
2015
Q2 		$845K Hold
8,689
– – 0.03% 342
2015
Q1 		$812K Hold
8,689
– – 0.03% 338
2014
Q4 		$773K Buy
+8,689
New +$633K 0.03% 338

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return